Previous studies have reported that butyrate had an anti‐inflammatory action in colon adenocarcinoma through inhibiting NF‐κB pathway (Chen et al., 2018; Lhrs et al., 2001). This evidence concerns the gene NFKB1 and colon adenocarcinoma.